SPP1 and Duchenne muscular dystrophy: Among these, an emerging candidate for evaluating muscle regeneration in dystrophic animal models and DMD patients is serum osteopontin (OPN), an inflammatory cytokine and myogenic factor which has been recently found to be highly elevated in the early disease phase of CXMDJ (canine X-linked muscular dystrophy) dogs in Japan.